- SG$77.02m
- SG$77.55m
- $0.35m
Brief: Trendlines Group Says Received Conditional Commitments Of Up To US$22 Million For New Venture Fund
Brief: Trendlines Group To Issue 103.6 Mln New Ordinary Shares In Co To Librae Holdings
Invest In New Co
Brief: Trendlines Group Posts FY Net Loss Attributable Of $6.1 Mln
Brief: Trendlines Group Announces Intention To Open Innovation Center Focused On Developing Agrifood Technologies
Brief: Trendlines Group To Launch Agrifood Technologies Innovation Center In Singapore
Brief: Trendlines Group Posts Qtrly Total Comprehensive Profit Attributable $3.2 Mln
Brief: Trendlines Group Ltd Announces Cessation Of Business Development VP
Brief: Trendlines Group Announces Termination of Term Sheet and Joint Venture Agreement
Brief: Corrected-Trendlines Group Appointed Haim Brosh As CFO
Brief: Trendlines Group Gets Regulatory Clearance From U.S FDA For Superballtm Meniscus Repair System
Brief: Arcuro Medical Gets U.S. FDA Clearance For Superball Meniscus Repair System
Brief: Trendlines Group Announces Resignation Of Gabriela (Gabi) Heller As CFO
Brief: Trendlines Group Says Sirius Venture Capital E Participacoes To Invest In Certain Portfolio Cos
Brief: Trendlines Group Signs MoU With Nutreco Investments B.V.
Brief: Trendlines Group FY Total Comprehensive Income Attributable $4 Million
Brief: Trendlines Group Says Portfolio Co Received Regulatory Clearance From US FDA For Composite Sinus Stent
Brief: Trendlines Group unit entered into MOU with National Healthcare Group
Brief: Trendlines Group posts qtrly net income attributable to equity holders of co of US$3 mln